CN106957397A - Anti- all leak gel rubber materials and preparation method thereof - Google Patents
Anti- all leak gel rubber materials and preparation method thereof Download PDFInfo
- Publication number
- CN106957397A CN106957397A CN201710108203.6A CN201710108203A CN106957397A CN 106957397 A CN106957397 A CN 106957397A CN 201710108203 A CN201710108203 A CN 201710108203A CN 106957397 A CN106957397 A CN 106957397A
- Authority
- CN
- China
- Prior art keywords
- preparation
- hydrogel material
- rubber materials
- gel rubber
- arginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 106
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 239000000017 hydrogel Substances 0.000 claims abstract description 89
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000178 monomer Substances 0.000 claims abstract description 34
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 33
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 33
- 229930064664 L-arginine Natural products 0.000 claims abstract description 33
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 33
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 33
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 33
- 229960002477 riboflavin Drugs 0.000 claims abstract description 33
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 33
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 33
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 32
- 239000003054 catalyst Substances 0.000 claims abstract description 25
- 238000004132 cross linking Methods 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000000499 gel Substances 0.000 claims description 23
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 16
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 16
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 16
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 11
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 239000004584 polyacrylic acid Substances 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 5
- 239000003599 detergent Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 150000004040 pyrrolidinones Chemical class 0.000 claims description 2
- YYPNJNDODFVZLE-UHFFFAOYSA-N 3-methylbut-2-enoic acid Chemical compound CC(C)=CC(O)=O YYPNJNDODFVZLE-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 42
- 238000010521 absorption reaction Methods 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 13
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000008055 phosphate buffer solution Substances 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- 239000000047 product Substances 0.000 description 28
- 229920000193 polymethacrylate Polymers 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 230000002265 prevention Effects 0.000 description 9
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 8
- 230000007935 neutral effect Effects 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 229910019142 PO4 Inorganic materials 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 5
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 5
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000004971 Cross linker Substances 0.000 description 4
- 208000032750 Device leakage Diseases 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 4
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 4
- 210000003709 heart valve Anatomy 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 206010002906 aortic stenosis Diseases 0.000 description 3
- 210000001765 aortic valve Anatomy 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000003017 Aortic Valve Stenosis Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 206010014665 endocarditis Diseases 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000003430 Mitral Valve Prolapse Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000012382 advanced drug delivery Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 201000001505 hemoglobinuria Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 201000007119 infective endocarditis Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
- C08F290/06—Polymers provided for in subclass C08G
- C08F290/062—Polyethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F285/00—Macromolecular compounds obtained by polymerising monomers on to preformed graft polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
本发明公开一种防周漏水凝胶材料及其制备方法,所述制备方法包括步骤:将制备水凝胶材料的亲水性单体和交联剂按比例混合溶于磷酸缓冲液中,然后加入由维生素B2和L‑精氨酸组成的催化剂,混合均匀后倒入模具中,常温下,在紫外光下进行交联,得到水凝胶材料产物,然后用酒精洗涤,除去未反应的单体和催化剂,然后烘干,得到防周漏水凝胶材料。本发明制备方法通过采用维生素B2和L‑精氨酸催化剂体系催化交联反应,所采用的均为生物相容性良好的原料,采用绿色合成路线,具有操作简单、成本较低、普适性广、可控性高的优点。采用本发明制备方法制得的防周漏水凝胶材料,厚度均匀,柔韧性良好,吸水速度快,具有良好的防周漏效果。The invention discloses an anti-circumferential hydrogel material and a preparation method thereof. The preparation method comprises the steps of: mixing and dissolving a hydrophilic monomer and a cross-linking agent for preparing the hydrogel material in proportion to a phosphate buffer solution, and then Add a catalyst composed of vitamin B2 and L-arginine, mix it evenly, pour it into a mold, and carry out cross-linking under ultraviolet light at room temperature to obtain a hydrogel material product, and then wash it with alcohol to remove unreacted monomers. body and catalyst, and then dried to obtain the anti-circumferential leakage hydrogel material. The preparation method of the present invention catalyzes the cross-linking reaction by adopting vitamin B2 and L-arginine catalyst system, adopts raw materials with good biocompatibility, adopts green synthesis route, has simple operation, low cost and universal applicability Wide range and high controllability. The anti-peripheral leakage hydrogel material prepared by the preparation method of the invention has uniform thickness, good flexibility, fast water absorption and good anti-peripheral leakage effect.
Description
技术领域technical field
本发明涉及生物医学材料领域,尤其涉及防周漏水凝胶材料及其制备方法。The invention relates to the field of biomedical materials, in particular to an anti-circumferential hydrogel material and a preparation method thereof.
背景技术Background technique
主动脉狭窄(主动脉瓣狭窄)是指各种原因导致主动脉瓣肥厚、钙化和/或瓣叶、瓣膜融合,进而导致左室流出道梗阻的一种疾病。随着人口老龄化的加深,主动脉瓣狭窄的发病率在逐渐增加,在我国已经成为仅次于二尖瓣脱垂的常见心脏瓣膜病。在过去的50年里,外科手术植入人工瓣膜是比较成功的治疗方式。然而,这种手术需要开胸进行,对于一些高龄和身体条件弱的患者来说,这种手术方式风险太高。目前,针对这种情况,经导管主动脉瓣植入术(TAVI)是最有发展前景的技术。Aortic stenosis (aortic valve stenosis) refers to a disease in which various reasons lead to aortic valve hypertrophy, calcification and/or valve leaflets, valve fusion, and then lead to left ventricular outflow tract obstruction. With the deepening of population aging, the incidence of aortic valve stenosis is gradually increasing, and it has become the second most common heart valve disease in my country after mitral valve prolapse. Over the past 50 years, surgical implantation of prosthetic valves has been the most successful treatment. However, this kind of surgery requires open chest, which is too risky for some elderly and weak patients. Currently, transcatheter aortic valve implantation (TAVI) is the most promising technology for this situation.
经导管主动脉瓣植入是一种在不切除原有病变瓣膜的基础上,通过导管经外周动脉或者心尖路径送入生物瓣膜,依靠球囊扩张和瓣膜的锚定装置固定的手术。先将人工心脏瓣膜压缩到一种输送器中,输送器通过血管将瓣膜输送到心脏病变处,然后释放人工心脏瓣膜使其代替病变的自体瓣膜。瓣周漏(PPL)是瓣膜置换术后特有的严重并发症,是常见的再手术原因之一。其发生原因主要与瓣环组织的病理改变、人造瓣膜与瓣环大小不匹配、以及人造瓣膜心内膜炎有关。瓣周漏发生后,常常伴随下列危害:(1)瓣周漏导致严重的溶血、贫血及血红蛋白尿进行性加重;(2)瓣周漏漏口较大引起血流动力学的异常改变,使心功能减退甚至发生心力衰竭,经内科保守治疗后症状及体征改善不明显;(3)瓣周漏漏口虽小,但合并有感染性心内膜炎;(4)瓣周漏合并生物瓣衰败。Transcatheter aortic valve implantation is a surgery in which a bioprosthetic valve is delivered through a catheter through the peripheral artery or the apical route without removing the original diseased valve, and is fixed by balloon expansion and valve anchoring device. The artificial heart valve is first compressed into a delivery device, which delivers the valve to the heart lesion through the blood vessel, and then releases the artificial heart valve to replace the diseased native valve. Perivalvular leak (PPL) is a unique serious complication after valve replacement and is one of the common reasons for reoperation. The main reasons for its occurrence are the pathological changes of the valve ring tissue, the size mismatch between the artificial valve and the valve ring, and the endocarditis of the artificial valve. After paravalvular leak occurs, it is often accompanied by the following hazards: (1) paravalvular leak leads to severe hemolysis, anemia and progressive aggravation of hemoglobinuria; (2) large paravalvular leak causes abnormal changes in hemodynamics, making Decreased heart function or even heart failure, and the symptoms and signs did not improve significantly after conservative medical treatment; (3) The pervalvular leak is small, but it is complicated with infective endocarditis; (4) The paravalvular leak is complicated with bioprosthesis decay.
目前商业上发展的心脏瓣膜有球囊式扩张瓣膜或自膨胀式瓣膜,人工心脏瓣膜置换装置一般包括由记忆金属材料制成的网状的支架,以及缝在该支架内的可单向开放的瓣膜构成,通过支架的膨胀力量与病变位置尽量吻合,虽然能够一定限度上降低瓣周漏,但因自体钙化后血管内壁的不规则形态,依然会出现不同程度的瓣周漏和外周返流。Currently commercially developed heart valves include balloon-expandable valves or self-expanding valves. Artificial heart valve replacement devices generally include a mesh-like stent made of memory metal materials, and a one-way openable stent sewn into the stent. The valve structure matches the lesion position as much as possible through the expansion force of the stent. Although paravalvular leakage can be reduced to a certain extent, due to the irregular shape of the inner wall of the blood vessel after autogenous calcification, different degrees of paravalvular leakage and peripheral regurgitation will still occur.
迄今为止,采用了各种办法来进行密封处理来提高防周漏的效果。US7780725B2,US0122587A1等采用在瓣膜末端增加裙边来达到一定的防周漏效果,US7577477采用注射纤维蛋白胶来密封,但是这两种情况均只适用于轻微周漏的情况。CN105232187A,CN103889472B通过采用密封的水凝胶构件来达到防周漏的效果,所使用的过硫酸铵(APS)和四甲基乙二胺(TEMED)催化剂体系具有快速成胶的效果,但是没有反应的过氧化物和TEMED会破坏蛋白质(W.E.Hennink,Advanced Drug Delivery Reviews,第64期,223-226页),同时成胶速度太快(一般在30秒内发生固化),不利于成型。So far, various methods have been adopted to carry out sealing treatment to improve the effect of preventing leakage. US7780725B2, US0122587A1 etc. add skirts at the end of the valve to achieve a certain anti-peripheral leakage effect, and US7577477 uses injection of fibrin glue to seal, but these two cases are only applicable to the situation of slight peripheral leakage. CN105232187A, CN103889472B reach the effect of anti-circumferential leakage by adopting the hydrogel component of sealing, the used ammonium persulfate (APS) and tetramethylethylenediamine (TEMED) catalyst system have the effect of gelling fast, but do not have reaction The peroxide and TEMED will destroy the protein (W.E.Hennink, Advanced Drug Delivery Reviews, No. 64, pages 223-226), and the gelation speed is too fast (generally curing within 30 seconds), which is not conducive to molding.
因此,现有技术还有待于改进和发展。Therefore, the prior art still needs to be improved and developed.
发明内容Contents of the invention
鉴于上述现有技术的不足,本发明的目的在于提供一种防周漏水凝胶材料及其制备方法,旨在解决采用现有的方法制备防周漏水凝胶材料时,未反应的过氧化物和催化剂会破坏蛋白质,同时成胶速度过快,不利于成型的问题。In view of the above-mentioned deficiencies in the prior art, the object of the present invention is to provide a kind of anti-period leakage hydrogel material and its preparation method, aiming to solve the problem of unreacted peroxide And the catalyst will destroy the protein, and the speed of gelation is too fast, which is not conducive to the problem of molding.
实现本发明的技术方案如下:Realize the technical scheme of the present invention as follows:
提供一种防周漏水凝胶材料的制备方法,包括步骤:A method for preparing an anti-circumferential hydrogel material is provided, comprising the steps of:
将制备水凝胶材料的亲水性单体和交联剂按比例混合溶于磷酸缓冲液中,然后加入由维生素B2和L-精氨酸组成的催化剂,混合均匀后倒入模具中,常温下,在300~400nm波长的紫外光下进行交联,得到水凝胶材料产物;Mix the hydrophilic monomers and cross-linking agents for preparing hydrogel materials in proportion and dissolve them in phosphate buffer solution, then add a catalyst composed of vitamin B2 and L-arginine, mix them evenly, and pour them into the mold, at room temperature Cross-linking under ultraviolet light with a wavelength of 300-400nm to obtain a hydrogel material product;
将所述水凝胶材料产物用洗涤剂进行洗涤,除去未反应的单体和催化剂,然后烘干,得到防周漏水凝胶材料。The hydrogel material product is washed with a detergent to remove unreacted monomers and catalysts, and then dried to obtain an anti-peripheral leakage hydrogel material.
所述的防周漏水凝胶材料的制备方法,其中,所述制备水凝胶材料的亲水性单体包括丙烯酸、丙烯酸酯、甲基丙烯酸、甲基丙烯酸酯、丙烯酰胺、N-乙烯基吡咯烷酮中的一种或两种及以上的组合。The preparation method of the anti-peripheral leakage hydrogel material, wherein, the hydrophilic monomer for preparing the hydrogel material includes acrylic acid, acrylate, methacrylic acid, methacrylate, acrylamide, N-vinyl One or a combination of two or more of pyrrolidones.
所述的防周漏水凝胶材料的制备方法,其中,所述交联剂包括聚乙二醇二甲基丙烯酸酯、聚乙烯醇接枝甲基丙烯酸酯、聚丙烯酸接枝甲基丙烯酸酯中的一种或两种及以上的组合。The preparation method of the anti-circumferential leakage hydrogel material, wherein, the crosslinking agent includes polyethylene glycol dimethacrylate, polyvinyl alcohol grafted methacrylate, polyacrylic acid grafted methacrylate One or a combination of two or more.
所述的防周漏水凝胶材料的制备方法,其中,按质量计,所述易于光引发聚合的亲水性单体和交联剂的添加比例为(3~6):(0.1~0.56)。The preparation method of the anti-circumferential leakage hydrogel material, wherein, by mass, the addition ratio of the hydrophilic monomer and the cross-linking agent that is prone to photoinitiated polymerization is (3-6): (0.1-0.56) .
所述的防周漏水凝胶材料的制备方法,其中,按质量计,所述由维生素B2和L-精氨酸组成的催化剂中,维生素B2:L-精氨酸=2~16:1。The preparation method of the anti-peripheral leakage hydrogel material, wherein, in terms of mass, in the catalyst composed of vitamin B2 and L-arginine, vitamin B2:L-arginine=2˜16:1.
所述的防周漏水凝胶材料的制备方法,其中,按质量计,所述由维生素B2和L-精氨酸组成的催化剂中,维生素B2:L-精氨酸=4~8:1。The preparation method of the anti-peripheral leakage hydrogel material, wherein, in terms of mass, in the catalyst composed of vitamin B2 and L-arginine, vitamin B2:L-arginine=4-8:1.
所述的防周漏水凝胶材料的制备方法,其中,常温下,在365nm波长的紫外光下进行交联1~3h,得到水凝胶材料产物。The preparation method of the anti-circumferential leakage hydrogel material, wherein, at normal temperature, cross-linking is carried out under ultraviolet light with a wavelength of 365nm for 1-3 hours to obtain the hydrogel material product.
所述的防周漏水凝胶材料的制备方法,其中,将所述水凝胶材料产物用酒精洗涤的步骤具体包括:先后用50%的酒精,75%的酒精和无水酒精各洗涤至少1次,每次洗涤20~40min。The preparation method of the anti-peripheral leakage hydrogel material, wherein, the step of washing the hydrogel material product with alcohol specifically includes: successively washing with 50% alcohol, 75% alcohol and absolute alcohol for at least 1 times, each washing 20 ~ 40min.
所述的防周漏水凝胶材料的制备方法,其中,所述烘干温度为30~50℃。The preparation method of the anti-circumferential leakage hydrogel material, wherein, the drying temperature is 30-50°C.
本发明还提供一种防周漏水凝胶材料包括按质量比计为(3~6):(0.1~0.56)的亲水性单体和交联剂;其中,所述的亲水性单体包括丙烯酸、丙烯酸酯、甲基丙烯酸、甲基丙烯酸酯、丙烯酰胺、N-乙烯基吡咯烷酮中的一种或两种以上的组合;所述交联剂包括聚乙二醇二甲基丙烯酸酯、聚乙烯醇接枝甲基丙烯酸酯、聚丙烯酸接枝甲基丙烯酸酯中的一种或两种以上的组合。The present invention also provides an anti-peripheral leakage hydrogel material comprising a hydrophilic monomer and a cross-linking agent in a mass ratio of (3-6):(0.1-0.56); wherein, the hydrophilic monomer including one or a combination of two or more of acrylic acid, acrylate, methacrylic acid, methacrylate, acrylamide, N-vinylpyrrolidone; the crosslinking agent includes polyethylene glycol dimethacrylate, One or more combinations of polyvinyl alcohol grafted methacrylate and polyacrylic acid grafted methacrylate.
本发明提供了另一种防周漏水凝胶材料,其采用以上任一项所述的制备方法制成。The present invention provides another anti-peripheral leakage hydrogel material, which is prepared by any one of the above preparation methods.
有益效果:本发明制备方法通过采用维生素B2和L-精氨酸催化剂体系催化交联反应,所采用的均为生物相容性良好的原料,采用绿色合成路线,具有操作简单、成本较低、普适性广、可控性高的优点。采用本发明所述制备方法制得的防周漏水凝胶材料,厚度均匀,柔韧性良好,吸水速度快具有良好的防周漏效果。Beneficial effects: the preparation method of the present invention uses vitamin B2 and L-arginine catalyst system to catalyze the cross-linking reaction, adopts raw materials with good biocompatibility, adopts green synthesis route, has the advantages of simple operation, low cost, The advantages of wide applicability and high controllability. The anti-peripheral leakage hydrogel material prepared by the preparation method of the invention has uniform thickness, good flexibility, fast water absorption and good anti-peripheral leakage effect.
具体实施方式detailed description
本发明提供一种防周漏水凝胶材料及其制备方法,为使本发明的目的、技术方案及效果更加清楚、明确,以下对本发明进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。The present invention provides an anti-peripheral leakage hydrogel material and its preparation method. In order to make the purpose, technical solution and effect of the present invention clearer and clearer, the present invention will be further described in detail below. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
与现有的采用过硫酸铵(APS)和四甲基乙二胺(TEMED)具有生物毒性的催化剂体系相比,本发明创造性的采用绿色的维生素B2和L-精氨酸催化剂体系进行紫外聚合,制备得到原位快速膨胀的防周漏水凝胶密封材料,具有良好的防周漏效果,能够防止血液回流,进一步改善手术效果,提高手术成功率,从而降低患者的心脏衰竭和死亡风险。Compared with the existing biotoxic catalyst system using ammonium persulfate (APS) and tetramethylethylenediamine (TEMED), the present invention uses green vitamin B2 and L-arginine catalyst system for ultraviolet polymerization , the in-situ rapidly expanding anti-peripheral leakage hydrogel sealing material is prepared, which has a good anti-peripheral leakage effect, can prevent blood backflow, further improve the operation effect, increase the success rate of the operation, thereby reducing the risk of heart failure and death of patients.
本发明防周漏水凝胶材料的制备方法,包括步骤:The preparation method of the anti-circumferential leakage hydrogel material of the present invention comprises steps:
S100、将制备水凝胶材料的亲水性单体和交联剂按比例混合溶于磷酸缓冲液中,然后加入由维生素B2和L-精氨酸组成的催化剂,混合均匀后倒入模具中,常温下,在300~400nm波长的紫外光下进行交联,得到水凝胶材料产物;紫外光的波长优选365nm,也可以是300nm、320nm、350nm、400nm。S100. Mix and dissolve the hydrophilic monomer and cross-linking agent for preparing the hydrogel material in proportion to the phosphate buffer solution, then add the catalyst composed of vitamin B2 and L-arginine, mix well and pour it into the mold , at room temperature, cross-linking is carried out under ultraviolet light with a wavelength of 300-400nm to obtain a hydrogel material product; the wavelength of ultraviolet light is preferably 365nm, and can also be 300nm, 320nm, 350nm, or 400nm.
S200、将所述水凝胶材料产物用洗涤剂进行洗涤,除去未反应的单体和催化剂,然后烘干,得到防周漏水凝胶材料。所述的洗涤剂优选酒精,也可以是去离子水或其他能对水凝胶材料产物进行洗涤而除去未反应的单体和催化剂的材料。S200. Wash the hydrogel material product with a detergent to remove unreacted monomers and catalysts, and then dry it to obtain an anti-peripheral leakage hydrogel material. The detergent is preferably alcohol, and may also be deionized water or other materials capable of washing the hydrogel material product to remove unreacted monomers and catalysts.
本发明制备方法通过采用维生素B2和L-精氨酸催化剂体系催化交联反应,所采用的均为生物相容性良好的原料,采用绿色合成路线,具有操作简单、成本较低、普适性广、可控性高的优点。The preparation method of the present invention uses vitamin B2 and L-arginine catalyst system to catalyze the cross-linking reaction, all of which are raw materials with good biocompatibility, adopts a green synthesis route, and has the advantages of simple operation, low cost and universal applicability Wide range and high controllability.
进一步的,所述制备水凝胶材料的亲水性单体包括但不限于丙烯酸、丙烯酸酯、甲基丙烯酸、甲基丙烯酸酯、丙烯酰胺、N-乙烯基吡咯烷酮(NVP)中的一种或两种及以上的组合。以上所述亲水性单体均为易于光引发聚合的亲水性单体。Further, the hydrophilic monomer for preparing the hydrogel material includes but is not limited to one of acrylic acid, acrylate, methacrylic acid, methacrylate, acrylamide, N-vinylpyrrolidone (NVP) or A combination of two or more. The above-mentioned hydrophilic monomers are all hydrophilic monomers that are easy to be polymerized by photoinitiation.
进一步的,本发明所述交联剂为多甲基丙烯酸酯(>2),其包括但不限于聚乙二醇二甲基丙烯酸酯(分子量500D)、聚乙烯醇接枝甲基丙烯酸酯(PVA-GMA)、聚丙烯酸(分子量6万)接枝甲基丙烯酸酯(PAA-g-GMA)中的一种或两种及以上的组合。Further, the crosslinking agent of the present invention is polymethacrylate (>2), which includes but not limited to polyethylene glycol dimethacrylate (molecular weight 500D), polyvinyl alcohol grafted methacrylate ( One or a combination of two or more of PVA-GMA), polyacrylic acid (molecular weight: 60,000) grafted methacrylate (PAA-g-GMA).
单体的亲水性和交联剂的类型对得到的水凝胶的吸水率有着至关重要的影响。如表1所示,表1为不同多甲基丙烯酸酯交联剂对水凝胶性能的影响。从表1可以看出,实施例1~3采用丙烯酸为单体、聚乙二醇二甲基丙烯酸酯作为交联剂,比采用聚乙烯醇接枝甲基丙烯酸酯和聚丙烯酸接枝甲基丙烯酸酯作为交联剂,得到的水凝胶材料吸水率高。实施例4和5采用甲基丙烯酸羟乙酯(HEMA)和N-乙烯基吡咯烷酮单体与聚乙烯醇接枝甲基丙烯酸酯交联剂共聚得到的水凝胶材料的吸水率低于实施例2,这主要是由于甲基丙烯酸羟乙酯和N-乙烯基吡咯烷酮的亲水性弱于聚丙烯酸。The hydrophilicity of the monomer and the type of crosslinker have a crucial impact on the water absorption of the resulting hydrogel. As shown in Table 1, Table 1 shows the influence of different polymethacrylate crosslinking agents on the properties of hydrogels. As can be seen from Table 1, Examples 1 to 3 use acrylic acid as a monomer and polyethylene glycol dimethacrylate as a crosslinking agent, compared with the use of polyvinyl alcohol grafted methacrylate and polyacrylic acid grafted methyl Acrylate is used as a crosslinking agent, and the obtained hydrogel material has a high water absorption rate. The water absorption rate of the hydrogel material obtained by the copolymerization of hydroxyethyl methacrylate (HEMA) and N-vinylpyrrolidone monomer and polyvinyl alcohol grafted methacrylate crosslinking agent in Examples 4 and 5 is lower than that of Example 2. This is mainly due to the weaker hydrophilicity of hydroxyethyl methacrylate and N-vinylpyrrolidone than polyacrylic acid.
表1.不同多甲基丙烯酸酯交联剂对水凝胶性能的影响Table 1. Effect of different polymethacrylate crosslinkers on hydrogel properties
进一步的,本发明所述聚乙烯醇接枝多甲基丙烯酸酯由以下方法制备:将2g聚乙烯醇(分子量8万,全水解)溶于150mL纯水中,加入氢氧化钠调节pH=10.5,然后加入1mL甲基丙烯酸缩水甘油脂,在50℃下反应24h,然后用丙酮沉淀,真空干燥后,得到聚乙烯醇接枝多甲基丙烯酸酯。聚丙烯酸接枝多甲基丙烯酸酯的制备方法与聚乙烯醇接枝多甲基丙烯酸酯基本相同,不同的是其反应在pH=3.5的条件下进行。Further, the polyvinyl alcohol-grafted polymethacrylate of the present invention is prepared by the following method: 2 g of polyvinyl alcohol (molecular weight: 80,000, fully hydrolyzed) is dissolved in 150 mL of pure water, and sodium hydroxide is added to adjust the pH=10.5 , and then add 1mL glycidyl methacrylate, react at 50°C for 24h, then precipitate with acetone, and dry in vacuum to obtain polyvinyl alcohol grafted polymethacrylate. The preparation method of polyacrylic acid grafted polymethacrylate is basically the same as that of polyvinyl alcohol grafted polymethacrylate, the difference is that the reaction is carried out under the condition of pH=3.5.
优选的,按质量计,所述易于光引发聚合的亲水性单体和交联剂的添加比例为(3~6):(0.1~0.56)。例如,可以为3:0.1、4:0.3、6:0.56。Preferably, on a mass basis, the addition ratio of the hydrophilic monomer prone to photoinitiated polymerization and the crosslinking agent is (3-6): (0.1-0.56). For example, it can be 3:0.1, 4:0.3, 6:0.56.
交联剂用量也是影响吸水率的重要的因素,如表2所示,表2为实施例1条件下不同交联剂用量对水凝胶吸水率的影响(其中吸水率为30min后测得)。从表2中可以看出,随着交联剂用量的增加,吸水率逐渐降低。为获得高吸水率水凝胶,本发明采用的交联剂用量为0.1~0.56g。The amount of cross-linking agent is also an important factor affecting the water absorption rate, as shown in Table 2, and Table 2 is the influence of different cross-linking agent amounts on the water absorption rate of the hydrogel under the conditions of Example 1 (wherein the water absorption rate is measured after 30min) . It can be seen from Table 2 that with the increase of the amount of crosslinking agent, the water absorption rate gradually decreases. In order to obtain the hydrogel with a high water absorption rate, the dosage of the crosslinking agent used in the present invention is 0.1-0.56 g.
表2.实施例1条件下不同交联剂用量对水凝胶吸水率的影响Table 2. Effects of different crosslinking agent dosages on hydrogel water absorption under the conditions of Example 1
优选的,所述步骤S100中,将制备水凝胶材料的亲水性单体和交联剂按比例混合溶于磷酸缓冲液中后,先加入NaOH溶液调节pH值至中性,然后加入由维生素B2和L-精氨酸组成的催化剂。加入NaOH溶液调节pH值至中性可以提高交联反应的效率,有助于得到柔韧性、吸水率等性能参数更好的防周漏水凝胶材料。Preferably, in the step S100, after mixing and dissolving the hydrophilic monomer and the cross-linking agent for preparing the hydrogel material in proportion to the phosphate buffer, first adding NaOH solution to adjust the pH value to neutral, and then adding the Catalyst composed of vitamin B2 and L-arginine. Adding NaOH solution to adjust the pH value to neutral can improve the efficiency of the crosslinking reaction, and help to obtain an anti-circumferential hydrogel material with better performance parameters such as flexibility and water absorption.
优选的,按质量计,所述由维生素B2和L-精氨酸组成的催化剂中,维生素B2:L-精氨酸=2~16:1。例如,可以为2:1、10:1、16:1。Preferably, in terms of mass, in the catalyst composed of vitamin B2 and L-arginine, vitamin B2:L-arginine=2˜16:1. For example, it can be 2:1, 10:1, 16:1.
更优选的,按质量计,所述由维生素B2和L-精氨酸组成的催化剂中,维生素B2:L-精氨酸=4~8:1。例如,可以为4:1、6:1、8:1。More preferably, in terms of mass, in the catalyst composed of vitamin B2 and L-arginine, vitamin B2:L-arginine=4˜8:1. For example, it can be 4:1, 6:1, 8:1.
维生素B2和L-精氨酸联组合用来生成引发活性种,因此两者的比例对于引发效率有着很大的影响,当L-精氨酸:维生素B2在比例为2:1~16:1时,单体转化率高于80%。The combination of vitamin B2 and L-arginine is used to generate the initiating active species, so the ratio of the two has a great influence on the initiating efficiency. When the ratio of L-arginine: vitamin B2 is 2:1~16:1 , the monomer conversion was higher than 80%.
进一步的,所述步骤S100中,所述磷酸缓冲液(磷酸盐缓冲液,PBS)为pH7.4的磷酸盐缓冲溶液。Further, in the step S100, the phosphate buffer solution (phosphate buffer saline, PBS) is a phosphate buffer solution with a pH of 7.4.
进一步的,所述步骤S100中,常温下,在365nm波长的紫外光下进行交联1~3h,得到水凝胶材料产物。Further, in the step S100, cross-linking is carried out under ultraviolet light with a wavelength of 365 nm for 1-3 hours at room temperature to obtain a hydrogel material product.
本发明中,紫外交联制备的水凝胶中仍然有未反应的单体,由于丙烯酸等单体溶于水和乙醇,所以采用乙醇溶液洗涤,除去未反应单体。In the present invention, there are still unreacted monomers in the hydrogel prepared by ultraviolet crosslinking. Since monomers such as acrylic acid are soluble in water and ethanol, the unreacted monomers are removed by washing with ethanol solution.
进一步的,所述步骤S200中,将所述水凝胶材料产物用酒精洗涤的步骤具体包括:先后用50%的酒精,75%的酒精和无水酒精各洗涤至少1次,每次洗涤20~40min。例如,用50%的酒精,75%的酒精和无水酒精分别洗涤1次,每次洗涤30min。Further, in the step S200, the step of washing the hydrogel material product with alcohol specifically includes: successively washing with 50% alcohol, 75% alcohol and absolute alcohol for at least one time each, and washing for 20 ~40min. For example, wash with 50% alcohol, 75% alcohol and absolute alcohol for 1 time, each time for 30 minutes.
进一步的,所述步骤S200中,所述烘干温度为30~50℃。例如,可以为30℃、40℃、50℃。Further, in the step S200, the drying temperature is 30-50°C. For example, it may be 30°C, 40°C, or 50°C.
基于以上所述制备方法,本发明还提供一种防周漏水凝胶材料,其采用以上所述的制备方法制成。采用本发明所述制备方法制得的防周漏水凝胶材料,厚度均匀,柔韧性良好,吸水速度快,甚至能够达到原位快速扩展至原有体积40倍,具有良好的防周漏效果。Based on the above-mentioned preparation method, the present invention also provides an anti-peripheral leakage hydrogel material, which is prepared by the above-mentioned preparation method. The anti-circumferential leakage gel material prepared by the preparation method of the present invention has uniform thickness, good flexibility, fast water absorption speed, and can even rapidly expand to 40 times the original volume in situ, and has a good anti-circumferential leakage effect.
本发明通过调节催化剂体系比例以及交联剂的种类与用量,得到不同交联和吸水率的水凝胶。In the invention, hydrogels with different crosslinking and water absorption rates are obtained by adjusting the ratio of the catalyst system and the type and amount of the crosslinking agent.
需要说明的是,本发明中的化学试剂除特别声明外均为分析纯。It should be noted that the chemical reagents in the present invention are analytically pure unless otherwise stated.
本发明采用红外光谱确定反应转化率,通过吸水率测定来筛选合适的水凝胶膜材料。The invention adopts infrared spectrum to determine the reaction conversion rate, and screens suitable hydrogel membrane materials through water absorption measurement.
本发明制备的水凝胶材料干燥后的厚度低于300μm(微米),所得材料较为均匀,柔韧性良好,吸水速度快。本发明为绿色合成路线,所采用的均为生物相容性良好的原料,具有操作简单、成本较低,普适性广,可控性高的优点。The thickness of the hydrogel material prepared by the invention is less than 300 μm (micron) after drying, and the obtained material is relatively uniform, has good flexibility and fast water absorption speed. The invention is a green synthesis route, all materials used are good biocompatibility, and has the advantages of simple operation, low cost, wide applicability and high controllability.
本发明采用重量法测定水凝胶吸水率,称量烘干后的水凝胶(Wdry),然后将材料放在培养皿中,加入去离子水,待溶胀10min和30min后,取出称量水凝胶重量(Wwet),计算公式如下:The present invention adopts the gravimetric method to measure the water absorption rate of the hydrogel, weighs the dried hydrogel (W dry ), then puts the material in a petri dish, adds deionized water, and takes it out and weighs it after swelling for 10min and 30min. Hydrogel weight (W wet ), the calculation formula is as follows:
吸水率(100%)=(Wwet-Wdry)/Wdry。Water absorption (100%)=(W wet −W dry )/W dry .
下面以具体实施例对本发明做详细说明:The present invention is described in detail below with specific embodiment:
实施例1Example 1
(1)、将3.5g丙烯酸和0.14g聚乙二醇二甲基丙烯酸酯溶于20mL磷酸盐缓冲溶液(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在365nm波长的紫外交联仪中反应3h,得到水凝胶材料产物;(1) Dissolve 3.5g of acrylic acid and 0.14g of polyethylene glycol dimethacrylate in 20mL of phosphate buffer solution (pH7.4), add NaOH solution to adjust the pH to neutral, add 50mg of vitamin B2 and 400mg The L-arginine is mixed evenly and poured into a mold, and reacted for 3 hours in an ultraviolet crosslinking instrument with a wavelength of 365nm to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用50%、75%和无水酒精分别洗涤3次,每次30min,除去未反应单体,然后40℃烘干,得到防周漏水凝胶材料。(2), the hydrogel material product obtained in step (1) was washed 3 times with 50%, 75% and absolute alcohol respectively, each time for 30min, to remove unreacted monomers, and then dried at 40°C to obtain anti- Peripheral leaky hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为40~60倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 40 to 60 times in 30 minutes, with uniform thickness and good flexibility.
实施例2Example 2
(1)、将3.2g丙烯酸和0.2g聚乙烯醇接枝多甲基丙烯酸酯交联剂加入20mL磷酸盐(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在365nm波长的紫外交联仪中反应2h,得到水凝胶材料产物;(1), add 3.2g of acrylic acid and 0.2g of polyvinyl alcohol grafted polymethacrylate crosslinking agent into 20mL of phosphate (pH7.4), add NaOH solution to adjust the pH value to neutral, add 50mg of vitamin B2 and 400mg of L-arginine was mixed evenly and poured into a mold, and reacted for 2 hours in an ultraviolet crosslinking instrument with a wavelength of 365nm to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用50%、75%和无水酒精洗涤3次,每次30min,除去未反应单体,然后40℃烘干,得到防周漏水凝胶材料。(2), the hydrogel material product obtained in step (1) was washed 3 times with 50%, 75% and absolute alcohol respectively, each time for 30 minutes, to remove unreacted monomers, and then dried at 40°C to obtain anti-peripheral Leaky gel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为30~40倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 30 to 40 times in 30 minutes, with uniform thickness and good flexibility.
实施例3Example 3
(1)、将3g丙烯酸和0.2g聚丙烯酸接枝多甲基丙烯酸酯交联剂加入20mL磷酸盐(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在365nm波长的紫外交联仪中反应2h,得到水凝胶材料产物;(1), add 3g of acrylic acid and 0.2g of polyacrylic acid grafted polymethacrylate crosslinking agent to 20mL of phosphate (pH7.4), add NaOH solution to adjust the pH value to neutral, add 50mg of vitamin B2 and 400mg of L-arginine, mixed evenly, poured into a mold, and reacted for 2 hours in an ultraviolet crosslinking instrument with a wavelength of 365nm, to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用50%、75%和无水酒精分别洗涤1次,每次40min,然后40℃烘干,得到防周漏水凝胶材料。(2) The hydrogel material product obtained in step (1) was washed once with 50%, 75% and absolute alcohol, respectively, for 40 minutes each time, and then dried at 40° C. to obtain the anti-peripheral leakage hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为30~40倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 30 to 40 times in 30 minutes, with uniform thickness and good flexibility.
实施例4Example 4
(1)、将5.8g甲基丙烯酸羟乙酯和0.25g聚乙烯醇接枝多甲基丙烯酸酯交联剂加入20mL磷酸盐(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在365nm波长的紫外交联仪中反应2h,得到水凝胶材料产物;(1), add 5.8g hydroxyethyl methacrylate and 0.25g polyvinyl alcohol grafted polymethacrylate crosslinking agent into 20mL phosphate (pH7.4), add NaOH solution to adjust the pH value to neutral, Add 50mg of vitamin B2 and 400mg of L-arginine, mix evenly, pour into a mold, and react for 2 hours in an ultraviolet crosslinking instrument with a wavelength of 365nm to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用50%、75%和无水酒精分别洗涤1次,然后40℃烘干,得到水凝胶材料产物。(2) The hydrogel material product obtained in step (1) was washed once with 50%, 75% and absolute alcohol respectively, and then dried at 40° C. to obtain the hydrogel material product.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为20~30倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 20 to 30 times in 30 minutes, with uniform thickness and good flexibility.
实施例5Example 5
(1)、5g N-乙烯基吡咯烷酮和0.25g聚乙烯醇接枝多甲基丙烯酸酯交联剂加入20mLPBS(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在320nm波长的紫外交联仪中反应3h,得到水凝胶材料产物;(1), 5g N-vinylpyrrolidone and 0.25g polyvinyl alcohol grafted polymethacrylate crosslinking agent are added in 20mL PBS (pH7.4), add NaOH solution to adjust the pH value to neutrality, add 50mg vitamin B2 and 400mg of L-arginine was mixed evenly and poured into a mold, and reacted for 3 hours in an ultraviolet crosslinking instrument with a wavelength of 320nm to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用50%、75%和无水酒精分别洗涤1次,然后30℃烘干,得到防周漏水凝胶材料。(2) The hydrogel material product obtained in step (1) was washed once with 50%, 75% and absolute alcohol respectively, and then dried at 30° C. to obtain the anti-peripheral leakage hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为20~30倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 20 to 30 times in 30 minutes, with uniform thickness and good flexibility.
实施例6Example 6
(1)、6g N-乙烯基吡咯烷酮和0.56g聚乙烯醇接枝多甲基丙烯酸酯交联剂加入20mLPBS(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和100mg的L-精氨酸,混合均匀后倒入模具中,在365nm波长的紫外交联仪中反应1h,得到水凝胶材料产物;(1), 6g N-vinylpyrrolidone and 0.56g polyvinyl alcohol grafted polymethacrylate crosslinking agent are added in 20mL PBS (pH7.4), add NaOH solution to adjust the pH value to neutrality, add 50mg vitamin B2 and 100mg of L-arginine was mixed evenly and poured into a mold, and reacted for 1 hour in an ultraviolet crosslinker with a wavelength of 365nm to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用50%、75%和无水酒精分别洗涤1次,每次20min,然后50℃烘干,得到防周漏水凝胶材料。(2) The hydrogel material product obtained in step (1) was washed once with 50%, 75% and absolute alcohol, respectively, for 20 minutes each time, and then dried at 50° C. to obtain the anti-peripheral leakage hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为5~10倍,30min为10~20倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 5-10 times in 10 minutes and 10-20 times in 30 minutes, with uniform thickness and good flexibility.
实施例7Example 7
(1)、将3.2g丙烯酸和2.6g甲基丙烯酸羟乙酯与0.2g聚乙烯醇接枝多甲基丙烯酸酯交联剂加入20mL磷酸盐(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在400nm波长的紫外交联仪中反应2h,得到水凝胶材料产物;(1), add 3.2g acrylic acid and 2.6g hydroxyethyl methacrylate and 0.2g polyvinyl alcohol grafted polymethacrylate crosslinking agent to 20mL phosphate (pH7.4), add NaOH solution to adjust the pH value To neutrality, add 50mg of vitamin B2 and 400mg of L-arginine, mix evenly, pour into a mold, and react for 2 hours in a 400nm wavelength ultraviolet crosslinking apparatus to obtain a hydrogel material product;
(2)、将步骤(1)得到的水凝胶材料产物分别用75%酒精洗涤3次,每次30min,除去未反应单体,然后40℃烘干,得到防周漏水凝胶材料。(2) The hydrogel material product obtained in step (1) was washed with 75% alcohol three times, each time for 30 minutes, to remove unreacted monomers, and then dried at 40° C. to obtain an anti-peripheral leakage hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为30~40倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 30 to 40 times in 30 minutes, with uniform thickness and good flexibility.
实施例8Example 8
(1)、将5.8g N-乙烯基吡咯烷酮与0.1g聚乙烯醇接枝多甲基丙烯酸酯和0.1g聚乙二醇二甲基丙烯酸酯交联剂加入20mL磷酸盐(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在400nm波长的紫外交联仪中反应2h,得到水凝胶材料产物;(1), add 5.8g N-vinylpyrrolidone, 0.1g polyvinyl alcohol grafted polymethacrylate and 0.1g polyethylene glycol dimethacrylate crosslinking agent to 20mL phosphate (pH7.4) , adding NaOH solution to adjust the pH value to neutral, adding 50mg of vitamin B2 and 400mg of L-arginine, mixing evenly, pouring into the mold, and reacting for 2 hours in a UV crosslinking instrument with a wavelength of 400nm to obtain a hydrogel material product ;
(2)、将步骤(1)得到的水凝胶材料产物用去离子水洗涤5次,每次30min,除去未反应单体,然后40℃烘干,得到防周漏水凝胶材料。(2) The hydrogel material product obtained in step (1) was washed with deionized water for 5 times, each time for 30 minutes, to remove unreacted monomers, and then dried at 40° C. to obtain an anti-peripheral leakage hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为10~15倍,30min为30~40倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 10 to 15 times in 10 minutes and 30 to 40 times in 30 minutes, with uniform thickness and good flexibility.
实施例9Example 9
(1)、将3g丙烯酸、2g N-乙烯基吡咯烷酮和1g丙烯酰胺与0.1g聚乙二醇二甲基丙烯酸酯、0.1g聚乙烯醇接枝甲基丙烯酸酯交联剂加入20mL磷酸盐(pH7.4)中,加入NaOH溶液调节pH值至中性,加入50mg维生素B2和400mg的L-精氨酸,混合均匀后倒入模具中,在350nm波长的紫外交联仪中反应2h,得到水凝胶材料产物;(1), add 20mL phosphate ( pH7.4), add NaOH solution to adjust the pH value to neutral, add 50mg of vitamin B2 and 400mg of L-arginine, mix evenly, pour into the mold, react in a 350nm wavelength ultraviolet crosslinker for 2h, and obtain Hydrogel material products;
(2)、将步骤(1)得到的水凝胶材料产物分别用75%酒精洗涤3次,每次30min,除去未反应单体,然后40℃烘干,得到防周漏水凝胶材料。(2) The hydrogel material product obtained in step (1) was washed with 75% alcohol three times, each time for 30 minutes, to remove unreacted monomers, and then dried at 40° C. to obtain an anti-peripheral leakage hydrogel material.
本实施例制备的防周漏水凝胶材料为半透明,10min吸水率为5~10倍,30min为10~20倍,且厚度均匀,柔韧性良好。The water leakage prevention gel material prepared in this example is translucent, with a water absorption rate of 5-10 times in 10 minutes and 10-20 times in 30 minutes, with uniform thickness and good flexibility.
综上所述,本发明实施例提供的防周漏水凝胶材料及其制备方法,所述制备方法通过采用维生素B2和L-精氨酸催化剂体系催化交联反应,所采用的均为生物相容性良好的原料,采用绿色合成路线,具有操作简单、成本较低,普适性广,可控性高的优点。采用本发明所述制备方法制得的防周漏水凝胶材料,厚度均匀,柔韧性良好,吸水速度快,具有良好的防周漏效果。In summary, the anti-peripheral leakage hydrogel material and its preparation method provided by the embodiment of the present invention, the preparation method uses vitamin B2 and L-arginine catalyst system to catalyze the cross-linking reaction, all of which are biological phase The raw material with good capacity adopts a green synthesis route, which has the advantages of simple operation, low cost, wide applicability and high controllability. The anti-peripheral leakage hydrogel material prepared by the preparation method of the invention has uniform thickness, good flexibility, fast water absorption and good anti-peripheral leakage effect.
应当理解的是,本发明的应用不限于上述的举例,对本领域普通技术人员来说,可以根据上述说明加以改进或变换,所有这些改进和变换都应属于本发明所附权利要求的保护范围。It should be understood that the application of the present invention is not limited to the above examples, and those skilled in the art can make improvements or transformations according to the above descriptions, and all these improvements and transformations should belong to the protection scope of the appended claims of the present invention.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710108203.6A CN106957397A (en) | 2017-02-27 | 2017-02-27 | Anti- all leak gel rubber materials and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710108203.6A CN106957397A (en) | 2017-02-27 | 2017-02-27 | Anti- all leak gel rubber materials and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106957397A true CN106957397A (en) | 2017-07-18 |
Family
ID=59470052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710108203.6A Pending CN106957397A (en) | 2017-02-27 | 2017-02-27 | Anti- all leak gel rubber materials and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106957397A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111157603A (en) * | 2019-12-23 | 2020-05-15 | 杭州师范大学 | Method for quick-setting and leak-proofing of a small amount of separating gel for polyacrylamide gel plate making |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006062573A1 (en) * | 2004-12-03 | 2006-06-15 | 3M Innovative Properties Company | Process for making pressure sensitive adhesive hydrogels |
CN102325814A (en) * | 2009-01-14 | 2012-01-18 | 康奈尔大学 | Preparation of Biodegradable Hydrogels for Biomedical Applications |
CN105232187A (en) * | 2011-09-09 | 2016-01-13 | 安多拉米诺科学公司 | Means for controlled sealing of endovascular devices |
-
2017
- 2017-02-27 CN CN201710108203.6A patent/CN106957397A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006062573A1 (en) * | 2004-12-03 | 2006-06-15 | 3M Innovative Properties Company | Process for making pressure sensitive adhesive hydrogels |
CN102325814A (en) * | 2009-01-14 | 2012-01-18 | 康奈尔大学 | Preparation of Biodegradable Hydrogels for Biomedical Applications |
CN105232187A (en) * | 2011-09-09 | 2016-01-13 | 安多拉米诺科学公司 | Means for controlled sealing of endovascular devices |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111157603A (en) * | 2019-12-23 | 2020-05-15 | 杭州师范大学 | Method for quick-setting and leak-proofing of a small amount of separating gel for polyacrylamide gel plate making |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7043096B2 (en) | Manufacture, raw materials, products and use of photocrosslinkable hydrogel materials | |
Su et al. | Recent progress in using biomaterials as vitreous substitutes | |
Omidian et al. | Hydrogels | |
JP4951621B2 (en) | Optical lens | |
CN107964056A (en) | Preparation method, raw material, product and the application of optical coupling cross-linked hydrogel material | |
TW200848833A (en) | Production of ophthalmic devices based on photo-induced step growth polymerization | |
Luo et al. | Recent advances of intraocular lens materials and surface modification in cataract surgery | |
JP4118021B2 (en) | Positive anterior intraocular implant | |
CN105111471B (en) | A kind of medicament slow release type contact lens hydrogel material and preparation method and application | |
TW200821332A (en) | Novel polymers | |
JPH06509731A (en) | Drug-coated refractive anterior chamber insert | |
US20070269488A1 (en) | Hydrogel Nanocompsites for Ophthalmic Applications | |
US8192485B2 (en) | Reversible hydrogel systems and methods therefor | |
JP2020027247A (en) | Contact lens containing functional component, and product thereof | |
Rosenquist et al. | An injectable, shape-retaining collagen hydrogel cross-linked using thiol-maleimide click chemistry for sealing corneal perforations | |
CN103405807A (en) | Surface comblike polymer hydrophilic modified artificial lens and preparation method thereof | |
CN106397674A (en) | Temperature-sensitive postoperative adhesion cellulose modifying material and preparation method and application thereof | |
JP2018536055A (en) | Hydrophobic cross-linked cinnamon alcohol based acrylic copolymers for intraocular lenses | |
Raesian et al. | Preparation and characterization of fluorometholone molecular imprinted soft contact lenses as ocular controlled drug delivery systems | |
CN110511400A (en) | Copolymer photoreversible hydrogel based on zwitterionic compound and coumarin derivative and its preparation method | |
JP4942060B2 (en) | Covalently hydrophilic hydrophilic coating composition for implants | |
CN106957397A (en) | Anti- all leak gel rubber materials and preparation method thereof | |
Kulbay et al. | Smart molecules in ophthalmology: Hydrogels as responsive systems for ophthalmic applications | |
CN101856508A (en) | Novel ophthalmic hydrogel tissue filler | |
CN101214217A (en) | Hydrogel-hydrogel composite material and its preparation method and application of drug slow-release matrix |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 310000 3 building 311, 88 Jiangling Road, Binjiang District, Hangzhou, Zhejiang Applicant after: VENUS MEDTECH (HANGZHOU), Inc. Address before: The South Ring Road of Binjiang District Hangzhou 310000 Zhejiang province No. 3738 friends tax building East Room 201 Applicant before: VENUS MEDTECH (HANGZHOU), Inc. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 310000 Room 311, 3/F, Building No. 88, Jiangling Road, Binjiang District, Hangzhou City, Zhejiang Province Applicant after: Hangzhou Qiming Medical Devices Co.,Ltd. Address before: 310000 Room 311, 3/F, Building No. 88, Jiangling Road, Binjiang District, Hangzhou City, Zhejiang Province Applicant before: VENUS MEDTECH (HANGZHOU), Inc. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170718 |